MedPage Today7d
FDA OKs First Drug for Hyperphagia in Prader-Willi Syndrome
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...
Disability Scoop6d
FDA Green-Lights First Treatment For Prader-Willi Syndrome
Federal regulators are clearing a first-of-its-kind treatment for symptoms of a rare neurodevelopmental disorder that is characterized by insatiable hunger. The Food and Drug Administration approved a ...
Monthly Prescribing Reference6d
Vykat XR Approved to Treat Hyperphagia in Prader-Willi Syndrome
Credit: Solano Therapeutics. Vykat XR contains an extended-release formulation of diazoxide choline, the crystalline salt of diazoxide. Vykat XR is expected to be available in April 2025.
U.S. News & World Report7d
US FDA Approves First Treatment for Rare Genetic Disorder Prader-Willi Syndrome
US FDA Approves First Treatment for Rare Genetic Disorder Prader-Willi Syndrome By Sneha S K (Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to ...
Healio7d
FDA approves first therapy to treat hyperphagia in Prader-Willi syndrome
Please provide your email address to receive an email when new articles are posted on . Diazoxide choline extended-release is the first FDA-approved therapy to address hyperphagia in Prader-Willi ...
Reuters8d
US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome
FDA approves first treatment to treat insatiable hunger Vykat XR to be available in US from April 2025 — Soleno March 26 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved ...